University of Birmingham Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel

• Users may freely distribute the URL that is used to identify this publication. • Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private study or non-commercial research. • User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?) • Users may not further distribute the material nor use it for the purposes of commercial gain.

[1]  S. Mundell,et al.  Rapid genetic diagnosis of heritable platelet function disorders with next‐generation sequencing: proof‐of‐principle with Hermansky–Pudlak syndrome , 2012, Journal of thrombosis and haemostasis : JTH.

[2]  S. Mundell,et al.  An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets. , 2011, Blood.

[3]  Paul J. Harrison,et al.  Guidelines for the laboratory investigation of heritable disorders of platelet function , 2011, British journal of haematology.

[4]  S. Honda,et al.  Bleeding tendency and impaired platelet function in a patient carrying a heterozygous mutation in the thromboxane A2 receptor , 2011, Journal of thrombosis and haemostasis : JTH.

[5]  S. Mundell,et al.  A novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis. , 2010, Blood.

[6]  C. Oudin,et al.  Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations. , 2009, Blood.

[7]  C. Hermans,et al.  A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder , 2009, Journal of thrombosis and haemostasis : JTH.

[8]  M. Cattaneo,et al.  Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH , 2009, Journal of thrombosis and haemostasis : JTH.

[9]  N. Heddle,et al.  Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments , 2009, Journal of thrombosis and haemostasis : JTH.

[10]  H. Mani,et al.  Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary , 2008, Journal of thrombosis and haemostasis : JTH.

[11]  C. Hayward.  Diagnostic approach to platelet function disorders. , 2008, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[12]  P. Nurden,et al.  Congenital disorders associated with platelet dysfunctions , 2008, Thrombosis and Haemostasis.

[13]  F. Lussana,et al.  Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count. , 2007, Haematologica.

[14]  S. Watson,et al.  Reference curves for aggregation and ATP secretion to aid diagnose of platelet-based bleeding disorders: Effect of inhibition of ADP and thromboxane A2 pathways , 2007, Platelets.

[15]  M. Cattaneo,et al.  Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[16]  Gemma L. J. Fuller,et al.  A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. , 2006, Blood.

[17]  H. Mani,et al.  Use of native or platelet count adjusted platelet rich plasma for platelet aggregation measurements , 2005, Journal of Clinical Pathology.

[18]  M. Cattaneo.  Inherited platelet abnormalities. , 2005, Thrombosis research.

[19]  A. Rao,et al.  Inherited Defects in Platelet Signaling Mechanisms , 2004, Seminars in thrombosis and hemostasis.

[20]  S. Watson,et al.  Platelet-collagen interaction: is GPVI the central receptor? , 2003, Blood.

[21]  M. Cattaneo.  Inherited platelet‐based bleeding disorders , 2003, Journal of thrombosis and haemostasis : JTH.

[22]  Y. Aizawa,et al.  Mutations of the Platelet Thromboxane A2 (TXA2) Receptor in Patients Characterized by the Absence of TXA2–induced Platelet Aggregation despite Normal TXA2 Binding Activity , 1999, Thrombosis and Haemostasis.

[23]  Y. Aizawa,et al.  Pathogenetic Analysis of Five Cases with a Platelet Disorder Characterized by the Absence of Thromboxane A2(TXA2)-Induced Platelet Aggregation in Spite of Normal TXA2 Binding Activity , 1996, Thrombosis and Haemostasis.

[24]  S. Narumiya,et al.  Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. , 1994, The Journal of clinical investigation.

[25]  S. Mundell,et al.  Phenotypic approaches to gene mapping in platelet function disorders , 2010, Hämostaseologie.

[26]  Colin A. Johnson,et al.  A germline mutation in BLOC1S3/reduced pigmentation causes a novel variant of Hermansky-Pudlak syndrome (HPS8). , 2006, American journal of human genetics.